Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin

被引：0
|
作者：
Arrigo, Richard
Samanta, Arun
Griffith, Shanthini
Parekh, Ravish M.
Korogodsky, Maria
Rao, Kiran V.
Fisher, Adrian
Wilson, Dorian
Klein, Kenneth M.
Koneru, Baburao
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [41] Anemia is Not Predictive of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Virus Who are Treated with Pegylated Interferon and Ribavirin
    Giusto, Michela
    Rodriguez, Maria
    Navarro, Laia
    Rubin, Angel
    Aguilera, Victoria
    San-Juan, Fernando
    Ortiz, Cecilia
    Lopez-Andujar, Rafael
    Prieto, Martin
    Berenguer, Marina
    LIVER TRANSPLANTATION, 2011, 17 (11) : 1318 - 1327
  • [42] Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
    Cicinnati, V. R.
    Iacob, S.
    Klein, C. G.
    Baba, H. A.
    Sotiropoulos, G. C.
    Hilgard, P.
    Erim, Y.
    Broelsch, C. E.
    Gerken, G.
    Beckebaum, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) : 291 - 303
  • [43] Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus
    Cholongitas, E
    Samonakis, D
    Patch, D
    Senzolo, M
    Burroughs, AK
    Quaglia, A
    Dhillon, A
    TRANSPLANTATION, 2006, 81 (03) : 488 - 490
  • [44] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [45] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
  • [46] Interferon-alfa2B and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    Rakela, J
    HEPATOLOGY, 1999, 30 (04) : 656A - 656A
  • [47] Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    McGuire, B
    Crippin, JS
    Canjeevaram, HS
    Teperman, L
    Gish, RG
    Kwo, P
    Wright, TL
    Brass, C
    Balan, V
    Demetris, J
    Rakela, J
    HEPATOLOGY, 2000, 32 (04) : 216A - 216A
  • [48] Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study
    Tanaka, Tomohiro
    Sugawara, Yasuhiko
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Tamura, Sumihito
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kurosaki, Masayuki
    Izumi, Namiki
    Kokudo, Norihiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (02) : 144 - 150
  • [49] Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection
    Kapur, A
    Rodriguez, MJ
    Schecter, S
    Tzakis, AG
    Schiff, ER
    GASTROENTEROLOGY, 1998, 114 (04) : A1268 - A1268
  • [50] Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient
    Muramatsu, S
    Ku, YS
    Fukumoto, T
    Iwasaki, T
    Tominaga, M
    Kusunoki, N
    Yoon, S
    Kuroda, Y
    TRANSPLANTATION, 2000, 69 (09) : 1956 - 1958
12345